-
1
-
-
0030806436
-
Angiogenesis: New aspects relating to its initiation and control
-
Norrby K. Angiogenesis: new aspects relating to its initiation and control. APMIS 1997;105:417-437
-
(1997)
APMIS
, vol.105
, pp. 417-437
-
-
Norrby, K.1
-
2
-
-
0022648938
-
How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes Memorial Award Lecture
-
Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes Memorial Award Lecture. Cancer Res 1986;46:467-473
-
(1986)
Cancer Res
, vol.46
, pp. 467-473
-
-
Folkman, J.1
-
3
-
-
85013312416
-
Tumor angiogenesis: Therapeutic implications
-
Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-1186
-
(1971)
N Engl J Med
, vol.285
, pp. 1182-1186
-
-
Folkman, J.1
-
4
-
-
0024426525
-
Angiogenic properties of normal and psoriatic skin associated with epidermis, not dermis
-
Mahlotra R, Stenn KS, Fernandez LA, Braverman IM. Angiogenic properties of normal and psoriatic skin associated with epidermis, not dermis. Lab Invest 1989;61:162-165
-
(1989)
Lab Invest
, vol.61
, pp. 162-165
-
-
Mahlotra, R.1
Stenn, K.S.2
Fernandez, L.A.3
Braverman, I.M.4
-
5
-
-
0003520592
-
-
(DHEW pub. no. [NIH] 73-427, 1970.) Bethesda, MD: US Department of Health, Education and Welfare
-
Klein HA, Moorehead HB. Statistics on blindness in the model reporting area, 1969-1970. (DHEW pub. no. [NIH] 73-427, 1970.) Bethesda, MD: US Department of Health, Education and Welfare, 1973
-
(1973)
Statistics on Blindness in the Model Reporting Area, 1969-1970
-
-
Klein, H.A.1
Moorehead, H.B.2
-
6
-
-
0002451749
-
Vision disorders in diabetes. National Diabetes Data Group
-
(NIH publ. no. 85-1468). Bethesda, MD: US Department of Health and Human Services
-
Klein R, Klein BEK. Vision disorders in diabetes. In: National Diabetes Data Group. Diabetes in America: Diabetes Data Compiled 1984. (NIH publ. no. 85-1468). Bethesda, MD: US Department of Health and Human Services 1985:1-2
-
(1985)
Diabetes in America: Diabetes Data Compiled 1984
, pp. 1-2
-
-
Klein, R.1
Klein, B.E.K.2
-
7
-
-
0026339086
-
Detecting and treating retinopathy in patients with type 1 diabetes mellitus
-
Javitt JC, Aiello LP, Bassi LJ, et al. Detecting and treating retinopathy in patients with type 1 diabetes mellitus. Ophthalmology 1991;98:1565-1574
-
(1991)
Ophthalmology
, vol.98
, pp. 1565-1574
-
-
Javitt, J.C.1
Aiello, L.P.2
Bassi, L.J.3
-
8
-
-
0028074463
-
Preventive eye care in people with diabetes is cost saving to the federal government
-
Javitt JC, Aiello LP, Chiang YP, et al. Preventive eye care in people with diabetes is cost saving to the federal government. Diabetes Care 1994;17:909-917
-
(1994)
Diabetes Care
, vol.17
, pp. 909-917
-
-
Javitt, J.C.1
Aiello, L.P.2
Chiang, Y.P.3
-
9
-
-
0028896755
-
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XV. The long-term incidence of macular edema
-
Klein R, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XV. The long-term incidence of macular edema. Ophthalmology 1995;102:7-16
-
(1995)
Ophthalmology
, vol.102
, pp. 7-16
-
-
Klein, R.1
-
10
-
-
0024497878
-
Cost effectiveness of current approaches to the control of retinopathy in Type 1 diabetics
-
Javitt JC, Canner JK, Sommer A. Cost effectiveness of current approaches to the control of retinopathy in Type 1 diabetics. Ophthalmology 1989;96:255-264
-
(1989)
Ophthalmology
, vol.96
, pp. 255-264
-
-
Javitt, J.C.1
Canner, J.K.2
Sommer, A.3
-
11
-
-
0021136256
-
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years
-
Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-526
-
(1984)
Arch Ophthalmol
, vol.102
, pp. 520-526
-
-
Klein, R.1
Klein, B.E.2
Moss, S.E.3
-
12
-
-
0345512093
-
Photocoagulation of proliferative diabetic retinopathy [Diabetic Retinopathy Study rep No. 2
-
Diabetic Retinopathy Study Group Photocoagulation of proliferative diabetic retinopathy [Diabetic Retinopathy Study rep No. 2. Ophthalmology 1978;85:82
-
(1978)
Ophthalmology
, vol.85
, pp. 82
-
-
-
13
-
-
0025892104
-
Early photocoagulation for diabetic retinopathy [ETDRS rep. no. 9]
-
Early Treatment Diabetic Retinopathy Study Group. Early photocoagulation for diabetic retinopathy [ETDRS rep. no. 9]. Ophthalmology 1991;98:766-785
-
(1991)
Ophthalmology
, vol.98
, pp. 766-785
-
-
-
14
-
-
0000230096
-
The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal disease
-
Michaelson IC. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal disease. Trans Ophthalmol Soc UK 1998;68:137-180
-
(1998)
Trans Ophthalmol Soc UK
, vol.68
, pp. 137-180
-
-
Michaelson, I.C.1
-
15
-
-
0003100257
-
Retinal vascularization in health and disease
-
Ashton N. Retinal vascularization in health and disease. Am J Ophthalmol 1957;44:7-24
-
(1957)
Am J Ophthalmol
, vol.44
, pp. 7-24
-
-
Ashton, N.1
-
16
-
-
0029121235
-
Angiogenesis: Mechanistic insights, neovascular diseases, and therapeutic prospects
-
Battegay EJ. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. Mol Med 1995;73:333-346
-
(1995)
Mol Med
, vol.73
, pp. 333-346
-
-
Battegay, E.J.1
-
17
-
-
0024339705
-
The heparin binding (fibroblast) growth factor family of proteins
-
Burgess WH, Maciag T. The heparin binding (fibroblast) growth factor family of proteins. Ann Rev Biochem 1989;58:575-606
-
(1989)
Ann Rev Biochem
, vol.58
, pp. 575-606
-
-
Burgess, W.H.1
Maciag, T.2
-
18
-
-
0005911475
-
Endothelial cell-derived basic fibroblast growth factor: Synthesis and deposition into subendothelial extracellular matrix
-
Vlodavsky I, Folkman J, Sullivan R, et al. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA 1987;84(8):2292-2296
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, Issue.8
, pp. 2292-2296
-
-
Vlodavsky, I.1
Folkman, J.2
Sullivan, R.3
-
19
-
-
0026687865
-
Basic fibroblast growth factor (bFGF) immunolocalization in the rodent outer retina demonstrated with an anti-rodent bFGF antibody
-
Gao H, Hollyfield JG. Basic fibroblast growth factor (bFGF) immunolocalization in the rodent outer retina demonstrated with an anti-rodent bFGF antibody. Brain Res 1992;585:355-360
-
(1992)
Brain Res
, vol.585
, pp. 355-360
-
-
Gao, H.1
Hollyfield, J.G.2
-
20
-
-
2442549663
-
Basic fibroblast growth factor induces angiogenesis in vitro
-
Montesano R, Vassali JD, Baird A, et al. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 1986;83:7297-7301
-
(1986)
Proc Natl Acad Sci USA
, vol.83
, pp. 7297-7301
-
-
Montesano, R.1
Vassali, J.D.2
Baird, A.3
-
21
-
-
0022382632
-
Angiogenesis is stimulated by a tumor-derived endothelial cell growth factor
-
Shing Y, Folkman J, Haudenschild C, et al. Angiogenesis is stimulated by a tumor-derived endothelial cell growth factor. J Cell Biochem 1985;29:275-287
-
(1985)
J Cell Biochem
, vol.29
, pp. 275-287
-
-
Shing, Y.1
Folkman, J.2
Haudenschild, C.3
-
22
-
-
0022457546
-
Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast a growth factor
-
Abraham JA, Mergia A, Whang JL, et al. Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast a growth factor. Science 1986;233:545-548
-
(1986)
Science
, vol.233
, pp. 545-548
-
-
Abraham, J.A.1
Mergia, A.2
Whang, J.L.3
-
23
-
-
0025913891
-
Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma
-
Kandel J, Bossy-Wetzel E, Radvany F, et al. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 1991;66: 1095-1104
-
(1991)
Cell
, vol.66
, pp. 1095-1104
-
-
Kandel, J.1
Bossy-Wetzel, E.2
Radvany, F.3
-
24
-
-
0024352333
-
Growth factors are released by mechanically wounded endothelial cells
-
McNeil PL, Muthukrishman L, Warder E, D'Amore PA. Growth factors are released by mechanically wounded endothelial cells. J Cell Biol 1989;109(2):811-822
-
(1989)
J Cell Biol
, vol.109
, Issue.2
, pp. 811-822
-
-
McNeil, P.L.1
Muthukrishman, L.2
Warder, E.3
D'Amore, P.A.4
-
25
-
-
0025294817
-
Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy
-
Sivalingam A, Kenney J, Brown GC, et al. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 1990;108:869-872
-
(1990)
Arch Ophthalmol
, vol.108
, pp. 869-872
-
-
Sivalingam, A.1
Kenney, J.2
Brown, G.C.3
-
26
-
-
0027053487
-
Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro
-
Pepper M, Ferrara N, Orci L, Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Comm 1992;189:824-831
-
(1992)
Biochem Biophys Res Comm
, vol.189
, pp. 824-831
-
-
Pepper, M.1
Ferrara, N.2
Orci, L.3
Montesano, R.4
-
27
-
-
0021111648
-
Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
-
Senger DR, Galli SJ, Dvorak AM. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983;219:983-985
-
(1983)
Science
, vol.219
, pp. 983-985
-
-
Senger, D.R.1
Galli, S.J.2
Dvorak, A.M.3
-
28
-
-
0024801035
-
Vascular permeability factor, an endothelial cell mitogen related to PDGF
-
Keck PJ, Hauser SD, Krivi G. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989;246:1309-1312
-
(1989)
Science
, vol.246
, pp. 1309-1312
-
-
Keck, P.J.1
Hauser, S.D.2
Krivi, G.3
-
29
-
-
0024818355
-
Vascular Permeability factor is a secreted angiogenic mitogen
-
Leung DW, Cachianes G, Kunang WJ. Vascular Permeability factor is a secreted angiogenic mitogen. Science 1989;246:1306-1309
-
(1989)
Science
, vol.246
, pp. 1306-1309
-
-
Leung, D.W.1
Cachianes, G.2
Kunang, W.J.3
-
30
-
-
15644366961
-
Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective Beta isoform-selective inhibitor
-
Aiello LP, Bursell SE, Clermont A, et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective Beta isoform-selective inhibitor. Diabetes 1997;46:1473-1480
-
(1997)
Diabetes
, vol.46
, pp. 1473-1480
-
-
Aiello, L.P.1
Bursell, S.E.2
Clermont, A.3
-
31
-
-
0028883260
-
Comparative analysis of vascular endothelial growth factor (VEGF) receptors on retinal and aortic microvascular endothelial cells
-
Thieme H, Aiello LP, Takagi H, et al. Comparative analysis of vascular endothelial growth factor (VEGF) receptors on retinal and aortic microvascular endothelial cells. Diabetes 1994;44:98-103
-
(1994)
Diabetes
, vol.44
, pp. 98-103
-
-
Thieme, H.1
Aiello, L.P.2
Takagi, H.3
-
32
-
-
0028826101
-
Hypoxic regulation of vascular endothelial growth factor in retinal cells
-
Aiello LP, Northrup JM, Keyt BA, et al. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 1995;113(12):1538-1544
-
(1995)
Arch Ophthalmol
, vol.113
, Issue.12
, pp. 1538-1544
-
-
Aiello, L.P.1
Northrup, J.M.2
Keyt, B.A.3
-
33
-
-
0028786651
-
Inhibition of vascular endothelial growth factor suppresses retinal neovascularization in vivo
-
Aiello LP, Pierce EA, Foley ED, et al. Inhibition of vascular endothelial growth factor suppresses retinal neovascularization in vivo. Proc Natl Acad Sci USA 1995;92(23):10457-10461
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, Issue.23
, pp. 10457-10461
-
-
Aiello, L.P.1
Pierce, E.A.2
Foley, E.D.3
-
34
-
-
0030013610
-
Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy
-
Robinson GS, Pierce EA, Rook SL, et al. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci USA 1996; 93:4851-4856
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 4851-4856
-
-
Robinson, G.S.1
Pierce, E.A.2
Rook, S.L.3
-
35
-
-
0030067257
-
Inhibition of VEGF prevent ocular neovascularization in a non-human primate
-
Adamis A, et al. Inhibition of VEGF prevent ocular neovascularization in a non-human primate. Arch Ophthalmol 1996;114:66-71
-
(1996)
Arch Ophthalmol
, vol.114
, pp. 66-71
-
-
Adamis, A.1
-
36
-
-
0027942607
-
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal diseases
-
Aiello LP, Avery RL, Arrigg OG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal diseases. N Engl J Med 1994;331: 1480-1487
-
(1994)
N Engl J Med
, vol.331
, pp. 1480-1487
-
-
Aiello, L.P.1
Avery, R.L.2
Arrigg, O.G.3
-
37
-
-
0029739621
-
Localization of VEGF in human retina and choroid
-
Lutty GA, McLeod DS, Merges C, et al. Localization of VEGF in human retina and choroid. Arch Ophthalmol 1996;114:971-977
-
(1996)
Arch Ophthalmol
, vol.114
, pp. 971-977
-
-
Lutty, G.A.1
McLeod, D.S.2
Merges, C.3
-
38
-
-
0031018867
-
Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy
-
Amin RH, Frank RN, Kennedy A, et al. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1997;38:36-47
-
(1997)
Invest Ophthalmol Vis Sci
, vol.38
, pp. 36-47
-
-
Amin, R.H.1
Frank, R.N.2
Kennedy, A.3
-
39
-
-
0030770396
-
Vascular endothelial growth factor (VEGF) and severity of nonproliferative diabetic retinopathy (NPDR) mediate retinal hemodynamics in vivo: A potential role for VEGF in the progression of nonproliferative diabetic retinopathy
-
Clermont A, Aiello LP, Mori F, et al. Vascular endothelial growth factor (VEGF) and severity of nonproliferative diabetic retinopathy (NPDR) mediate retinal hemodynamics in vivo: A potential role for VEGF in the progression of nonproliferative diabetic retinopathy. Am J Ophthalmol 1997;124:433-446
-
(1997)
Am J Ophthalmol
, vol.124
, pp. 433-446
-
-
Clermont, A.1
Aiello, L.P.2
Mori, F.3
-
40
-
-
0028879632
-
Blood-ocular barrier breakdown in eyes with ocular melanoma. A potential role for vascular endothelial growth factor/vascular permeability factor
-
Vinores SA, Kuchle M, Mahlow J, et al. Blood-ocular barrier breakdown in eyes with ocular melanoma. A potential role for vascular endothelial growth factor/vascular permeability factor. Am J Pathol 1995;147:1289-1297
-
(1995)
Am J Pathol
, vol.147
, pp. 1289-1297
-
-
Vinores, S.A.1
Kuchle, M.2
Mahlow, J.3
-
41
-
-
0029879849
-
Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes
-
Lopez PF, Sippy BD, Lambert HM, et al. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Opthalmol Vis Sci 1996;37:855-868
-
(1996)
Invest Opthalmol Vis Sci
, vol.37
, pp. 855-868
-
-
Lopez, P.F.1
Sippy, B.D.2
Lambert, H.M.3
-
42
-
-
2642709170
-
Characterization of vascular endothelial growth factor's effect on the activation of phospholipase Cγ protein kinase C pathways and endothelial cell growth
-
Pu X, Aiello LP, Jiang ZY, et al. Characterization of vascular endothelial growth factor's effect on the activation of phospholipase Cγ protein kinase C pathways and endothelial cell growth. J Clin Invest 1996;98:2018-326
-
(1996)
J Clin Invest
, vol.98
, pp. 2018-2326
-
-
Pu, X.1
Aiello, L.P.2
Jiang, Z.Y.3
-
43
-
-
13344293711
-
Amelioration of vascular dysfunction in diabetic rats by an oral PKC β inhibitor
-
Ishii H, et al. Amelioration of vascular dysfunction in diabetic rats by an oral PKC β inhibitor. Science 1996;272:728-731
-
(1996)
Science
, vol.272
, pp. 728-731
-
-
Ishii, H.1
-
44
-
-
85047503908
-
The houssay phenomenon in man: Recovery from retinopathy in a case of diabetes with Simmonds' disease
-
Poulsen JE. The houssay phenomenon in man: recovery from retinopathy in a case of diabetes with Simmonds' disease. Diabetes 1958;2:7-12
-
(1958)
Diabetes
, vol.2
, pp. 7-12
-
-
Poulsen, J.E.1
-
45
-
-
0013882121
-
Diabetes and anterior pituitary insufficiency: Final course and postmortem study of a diabetic patient with Sheehan's syndrome
-
Poulsen JE. Diabetes and anterior pituitary insufficiency: final course and postmortem study of a diabetic patient with Sheehan's syndrome. Diabetes 1966;15:73-77
-
(1966)
Diabetes
, vol.15
, pp. 73-77
-
-
Poulsen, J.E.1
-
46
-
-
0017704479
-
Prolonged follow-up in diabetic retinopathy treated by sectioning the pituitary stalk
-
Zimmerman BR, Molnar GD. Prolonged follow-up in diabetic retinopathy treated by sectioning the pituitary stalk. Mayo Clin Proc 1977;52:233-237
-
(1977)
Mayo Clin Proc
, vol.52
, pp. 233-237
-
-
Zimmerman, B.R.1
Molnar, G.D.2
-
47
-
-
0018104186
-
Metabolic and clinical studies in growth hormone deficient dwarfs: A ten year follow-up
-
Merimee TJ. Metabolic and clinical studies in growth hormone deficient dwarfs: a ten year follow-up. N Engl J Med 1978;298:1217-1222
-
(1978)
N Engl J Med
, vol.298
, pp. 1217-1222
-
-
Merimee, T.J.1
-
48
-
-
0017337542
-
Retinopathy and plasma growth hormone levels in idiopathic hemochromatosis with diabetes
-
Passa R, Rousselie F, Gauville C, Canivet J. Retinopathy and plasma growth hormone levels in idiopathic hemochromatosis with diabetes. Diabetes 1977;26:113-120
-
(1977)
Diabetes
, vol.26
, pp. 113-120
-
-
Passa, R.1
Rousselie, F.2
Gauville, C.3
Canivet, J.4
-
49
-
-
0021349457
-
Growth hormone and endothelial function during exercise in diabetics with and without retinopathy
-
Sundkvist G, Almer L, Pandolfi M. Growth hormone and endothelial function during exercise in diabetics with and without retinopathy. Acta Med Scand 1984;215:55-61
-
(1984)
Acta Med Scand
, vol.215
, pp. 55-61
-
-
Sundkvist, G.1
Almer, L.2
Pandolfi, M.3
-
50
-
-
0020550445
-
Insulin-like growth factors: Studies in diabetics with and with retinopathy
-
Merimee TJ, Zapf J, Groesch ER. Insulin-like growth factors: studies in diabetics with and with retinopathy. N Engl J Med 1983;309:527-530
-
(1983)
N Engl J Med
, vol.309
, pp. 527-530
-
-
Merimee, T.J.1
Zapf, J.2
Groesch, E.R.3
-
51
-
-
0026343661
-
Association of elevated IGF-1 levels with increased retinopathy in late-onset diabetes
-
Dills DG, Moss SE, Klein R, Klein BE. Association of elevated IGF-1 levels with increased retinopathy in late-onset diabetes. Diabetes 1991;40:1724-1730
-
(1991)
Diabetes
, vol.40
, pp. 1724-1730
-
-
Dills, D.G.1
Moss, S.E.2
Klein, R.3
Klein, B.E.4
-
52
-
-
0022539028
-
Insulin-like growth factors in vitreous: Studies in controls and diabetics with neovascularization
-
Grant MB, Russel B, Fitgerald C, Merimee TJ. Insulin-like growth factors in vitreous: studies in controls and diabetics with neovascularization. Diabetes 1986;35:416-420
-
(1986)
Diabetes
, vol.35
, pp. 416-420
-
-
Grant, M.B.1
Russel, B.2
Fitgerald, C.3
Merimee, T.J.4
-
53
-
-
0028944958
-
Does insulin-like growth factor 1 predict incidence and progression of diabetic retinopathy
-
Wang Q, Dills DG, Klein R, et al. Does insulin-like growth factor 1 predict incidence and progression of diabetic retinopathy. Diabetes 1995;44:161-164
-
(1995)
Diabetes
, vol.44
, pp. 161-164
-
-
Wang, Q.1
Dills, D.G.2
Klein, R.3
-
54
-
-
0025366074
-
Insulin-like growth factor I stimulates prolifertion, migration, and plasminogen activator release by human retinal pigment epithelial cells
-
Grant MB, Guay C, Marsh R. Insulin-like growth factor I stimulates prolifertion, migration, and plasminogen activator release by human retinal pigment epithelial cells. Curr Eye Res 1990;9:323-335
-
(1990)
Curr Eye Res
, vol.9
, pp. 323-335
-
-
Grant, M.B.1
Guay, C.2
Marsh, R.3
-
55
-
-
0027433439
-
Insulin-like growth factor I as an antiangiogenic agent: In vivo and vitro studies
-
Grant MB, Mames RN, Fitgerals C, et al. Insulin-like growth factor I as an antiangiogenic agent: in vivo and vitro studies. Ann NY Acad Sci 1993;692:230-242
-
(1993)
Ann NY Acad Sci
, vol.692
, pp. 230-242
-
-
Grant, M.B.1
Mames, R.N.2
Fitgerals, C.3
-
56
-
-
0030863133
-
Essential role of growth hormone in ischemia-induced retinal neovascularization
-
Smith LEH, Kopchick JJ, Chen W, et al. Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 1997;276:1706-1709
-
(1997)
Science
, vol.276
, pp. 1706-1709
-
-
Smith, L.E.H.1
Kopchick, J.J.2
Chen, W.3
-
57
-
-
0026770377
-
Integrins: Versality, modulation and signaling in cell adhesion
-
Hynes RO. Integrins: versality, modulation and signaling in cell adhesion. Cell 1992;69: 11-25
-
(1992)
Cell
, vol.69
, pp. 11-25
-
-
Hynes, R.O.1
-
58
-
-
0027459771
-
Signal transduction from the extracellular matrix
-
Juliano RL, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol 1993; 120:577-585
-
(1993)
J Cell Biol
, vol.120
, pp. 577-585
-
-
Juliano, R.L.1
Haskill, S.2
-
60
-
-
0027982162
-
Integrins as dynamic regulators of vascular function
-
Luscinskas FW, Lawler J. Integrins as dynamic regulators of vascular function. FASEB J 1996;8:929-938
-
(1996)
FASEB J
, vol.8
, pp. 929-938
-
-
Luscinskas, F.W.1
Lawler, J.2
-
62
-
-
0030635917
-
vβ5 in angiogenesis
-
Goldberg ID, Rosen EM, eds. Basel: Birkhauser Verlag
-
vβ5 in angiogenesis. In: Goldberg ID, Rosen EM, eds. Regulation of angiogenesis. Basel: Birkhauser Verlag, 1997:361-390
-
(1997)
Regulation of Angiogenesis
, pp. 361-390
-
-
Varner, J.A.1
-
63
-
-
0001254182
-
Integrins: Structure, function and biological properties
-
Cheresh D. Integrins: structure, function and biological properties. Adv Mol Cell Biol 1993;6:225-252
-
(1993)
Adv Mol Cell Biol
, vol.6
, pp. 225-252
-
-
Cheresh, D.1
-
64
-
-
0028801218
-
Integrin function: Molecular hierarchies of cytoskeletal and signaling molecules
-
Miyamoto S, Teramoto H, Coso OA, et al. Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. J Cell Biol 1995;131:791-805
-
(1995)
J Cell Biol
, vol.131
, pp. 791-805
-
-
Miyamoto, S.1
Teramoto, H.2
Coso, O.A.3
-
65
-
-
0027679403
-
Integrin cytoplasmic domains: Mediators of cytoskeletal linkages and extra- and intracellular initiated transmembrane signaling
-
Sastry SK, Horwitz A. Integrin cytoplasmic domains: mediators of cytoskeletal linkages and extra- and intracellular initiated transmembrane signaling. Curr Opin Cell Biol 1993;5:819-832
-
(1993)
Curr Opin Cell Biol
, vol.5
, pp. 819-832
-
-
Sastry, S.K.1
Horwitz, A.2
-
66
-
-
0030484702
-
Role of integrins in angiogenesis
-
Brooks PC. Role of integrins in angiogenesis. Eur J Cancer 1996;14:2423-2429
-
(1996)
Eur J Cancer
, vol.14
, pp. 2423-2429
-
-
Brooks, P.C.1
-
67
-
-
0030117714
-
Cellular adhesion molecules: Newly identified mediators of angiogenesis
-
Polverini PJ. Cellular adhesion molecules: newly identified mediators of angiogenesis. Am J Pathol 1996;148:1023-1029
-
(1996)
Am J Pathol
, vol.148
, pp. 1023-1029
-
-
Polverini, P.J.1
-
68
-
-
0027008419
-
Basic FGF and TGF-β differential modulate integrin expression of human microvascular endothelial cells
-
Enenstein J, Walesh NS, Kramer RH. Basic FGF and TGF-β differential modulate integrin expression of human microvascular endothelial cells. Exp Cell Res 1992;203:499-503
-
(1992)
Exp Cell Res
, vol.203
, pp. 499-503
-
-
Enenstein, J.1
Walesh, N.S.2
Kramer, R.H.3
-
69
-
-
0026683840
-
Expression and modulation of vitronectin receptor on human dermal microvascular endothelial cells
-
Swerlick RA, Brown EJ, Xu Y, et al. Expression and modulation of vitronectin receptor on human dermal microvascular endothelial cells. J Invest Dermatol 1992;99:715-722
-
(1992)
J Invest Dermatol
, vol.99
, pp. 715-722
-
-
Swerlick, R.A.1
Brown, E.J.2
Xu, Y.3
-
70
-
-
0026586110
-
Antibodies to β1-integrins cause alterations of aortic vascularization in vivo
-
Drake CJ, Davis LA, Little CD. Antibodies to β1-integrins cause alterations of aortic vascularization in vivo. Dev Dyn 1991;193:83-91
-
(1991)
Dev Dyn
, vol.193
, pp. 83-91
-
-
Drake, C.J.1
Davis, L.A.2
Little, C.D.3
-
71
-
-
0028981497
-
3, prevents maturation of blood vessels during embryonic neovascularization
-
3, prevents maturation of blood vessels during embryonic neovascularization. J Cell Sci 1995;108:2655-2661
-
(1995)
J Cell Sci
, vol.108
, pp. 2655-2661
-
-
Drake, C.J.1
Cheresh, D.A.2
Little, C.D.3
-
72
-
-
0030809457
-
Targeted mutations in integrins and their ligands: Their implications for vascular biology
-
Hynes RO, Bader BL. Targeted mutations in integrins and their ligands: their implications for vascular biology. Thromb Haemost 1997;78:83-87
-
(1997)
Thromb Haemost
, vol.78
, pp. 83-87
-
-
Hynes, R.O.1
Bader, B.L.2
-
73
-
-
0030589587
-
Targeted mutations in cell adhesion genes: What have we learned from them?
-
Hynes RO. Targeted mutations in cell adhesion genes: what have we learned from them? Dev Biol 1996;180:40-412
-
(1996)
Dev Biol
, vol.180
, pp. 40-412
-
-
Hynes, R.O.1
-
74
-
-
0028143758
-
Confocal microscope analysis of integrin expression on the microvascular and its sprouts in the neonatal foreskin
-
Erenstein J, Kramer RH. Confocal microscope analysis of integrin expression on the microvascular and its sprouts in the neonatal foreskin. J Invest Dermatol 1994;103:381-386
-
(1994)
J Invest Dermatol
, vol.103
, pp. 381-386
-
-
Erenstein, J.1
Kramer, R.H.2
-
76
-
-
0028670833
-
3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
-
3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994;79:1157-1164
-
(1994)
Cell
, vol.79
, pp. 1157-1164
-
-
Brooks, P.C.1
Montgomery, A.M.P.2
Rosenfeld, M.3
-
78
-
-
0029925079
-
Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization
-
Hammes H-P, Brownlee M, Jonczyk A, et al. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nature Med 1996;5:529-533
-
(1996)
Nature Med
, vol.5
, pp. 529-533
-
-
Hammes, H.-P.1
Brownlee, M.2
Jonczyk, A.3
-
79
-
-
0029843947
-
Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases
-
Friedlander M, Theesfeld CL, Sugita M, et al. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc Natl Acad Sci USA 1996;93: 9764-9769
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 9764-9769
-
-
Friedlander, M.1
Theesfeld, C.L.2
Sugita, M.3
-
80
-
-
0029001244
-
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
-
Sato TN, Tozawa Y, Deutsch U, et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995;376:70-74
-
(1995)
Nature
, vol.376
, pp. 70-74
-
-
Sato, T.N.1
Tozawa, Y.2
Deutsch, U.3
-
81
-
-
0027368264
-
Tie-1 and Tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system
-
Sato TN, Qin Y, Kozak CA, Audus KL. Tie-1 and Tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc Natl Acad Sci USA 1993;90:9355-9358
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 9355-9358
-
-
Sato, T.N.1
Qin, Y.2
Kozak, C.A.3
Audus, K.L.4
-
82
-
-
0027515802
-
Expression of Tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage
-
Schnurch H, Risau W. Expression of Tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development 1993;119:957-968
-
(1993)
Development
, vol.119
, pp. 957-968
-
-
Schnurch, H.1
Risau, W.2
-
83
-
-
0028006242
-
The mouse tie receptor tyrosine kinase gene: Expression during embryonic angiogenesis
-
Korhonen J, Polvi A, Partanen J, and Alitalo K. The mouse tie receptor tyrosine kinase gene: expression during embryonic angiogenesis. Oncogene 1994;9:395-403
-
(1994)
Oncogene
, vol.9
, pp. 395-403
-
-
Korhonen, J.1
Polvi, A.2
Partanen, J.3
Alitalo, K.4
-
84
-
-
0030480322
-
Requisite role of Angiopoietin-1, a ligand for the TIE-2 receptor, during embryonic angiogenesis
-
Suri C, Jones PF, Patan S, et al. Requisite role of Angiopoietin-1, a ligand for the TIE-2 receptor, during embryonic angiogenesis. Cell 1996;87:1171-1180
-
(1996)
Cell
, vol.87
, pp. 1171-1180
-
-
Suri, C.1
Jones, P.F.2
Patan, S.3
-
85
-
-
15144358851
-
Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis
-
Maisonpierre PC, Suri C, Jones PJ, et al. Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis. Science 1997;277:55-60
-
(1997)
Science
, vol.277
, pp. 55-60
-
-
Maisonpierre, P.C.1
Suri, C.2
Jones, P.J.3
-
86
-
-
0030851764
-
Signaling vascular morphogenesis and maintenance
-
Hanahan D. Signaling vascular morphogenesis and maintenance. Science 1997;277: 48-50
-
(1997)
Science
, vol.277
, pp. 48-50
-
-
Hanahan, D.1
|